Abstract

Summary

This study provides the first neuroanatomical evidence that amyloid-β accumulation in the retina and visual pathway disrupts retinal projections to key light-processing and circadian centers—including the suprachiasmatic nucleus and lateral geniculate nucleus—in an Alzheimer's disease mouse model. These findings suggest that circadian lighting interventions in dementia care must contend with compromised photic input pathways, potentially limiting the effectiveness of light-based therapies in AD patients.
Abstract

Key Findings

  • Aβ accumulation was detected in the retina and retinorecipient areas of both early-stage (4-month-old) and late-stage (12-month-old) female 5XFAD transgenic mice.
  • Retinal efferents to the suprachiasmatic nucleus (SCN) and lateral geniculate nucleus (LGN) were impaired in early-stage (4-month-old) AD mice.
  • Retinal connections to the dorsal lateral geniculate nucleus (dLGN) and superior colliculus were further degenerated in late-stage (12-month-old) AD mice.
  • Fluorescence intensity of anterograde tracer (CTβ) in retinorecipient areas was quantifiably reduced in 5XFAD mice compared to wild-type controls, indicating measurable loss of visual circuit connectivity.
Categories

Categories

Dementia & Elder Care: Demonstrates Aβ-induced neurodegeneration in the visual pathway of an Alzheimer's disease mouse model, with implications for visual and circadian dysfunction in AD patients.
The Science of Light: Identifies impairment of retinal efferents to the suprachiasmatic nucleus (the master circadian clock) in early-stage AD, directly linking AD pathology to disrupted photic entrainment pathways.
Authors

Author(s)

Y Nam, S Kim, J Kim, HS Hoe, M Moon
Publication Date

Publication Year

2022
Citations

Number of Citations

1
View more publications